The ABBOS-peptide from bovine serum albumin causes an IFN-γ and IL-4 mRNA response in lymphocytes from children with recent onset of type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 47, Issue 3, 2000, Pages 199-207

  Karlsson, Maria G E ^a   Ludvigsson, Johnny ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

ABBOS; IFN ; IL 4; Th lymphocytes; Type 1 diabetes

Indexed keywords

ALBUMIN PEPTIDE; ALBUMINOID; BOVINE SERUM ALBUMIN; C PEPTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; INSULIN ANTIBODY; INTERLEUKIN 4; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CATTLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; HLA TYPING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; C-PEPTIDE; CATTLE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN ANTIBODIES; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTES; MIDDLE AGED; MILK; PEPTIDE FRAGMENTS; REFERENCE VALUES; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; TRANSCRIPTION, GENETIC;

EID: 0033971455     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00127-8     Document Type: Article

References (34)

1. Karjalainen J., Martin J.M., Knip M., Ilonen J., Robinson B.H., Savilahti E. et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. New Eng. J. Med. 327:1992;302-307.
2. Martin J.M., Trink B., Daneman D., Dosch H.-M., Robinson B. Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann. Med. 23:1991;447-452.
3. Karges W., Pietropaolo M., Ackerley C.A., Dosch H.-M. Gene expression of islet cell antigen p69 in human, mouse, and rat. Diabetes. 45:1996;513-521.
4. Glerum M., Robinson B.H., Martin J.M. Could bovine serum albumin be the initiating antigen ultimately responsible for the development of insulin dependent diabetes mellitus? Diabetes Res. 10:1989;103-107.
5. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K. et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
6. Atkinson M.A., Maclaren N.K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:1990;933-937.
7. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M. et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152:1994;3183-3188.
8. Baekkeskov S., Höiriis Nielsen J., Marner B., Bilde T., Ludvigsson J., Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 298:1982;167-169.
9. Baekkeskov S., Aanstoot H.-J., Christgau S., Reetz A., Solimena M., Cascalho M. et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
10. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P. et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
11. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
12. Baekkeskov S., Landin M., Kvist Kristensen J., Srikanta S., Bruining G.J., Mandrup-Poulsen T. et al. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 79:1987;926-934.
13. Kaufman D.L., Erlander M.G., Clare-Salzler M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89:1992;283-292.
14. Richter W., Shi Y., Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA. 90:1993;2832-2836.
15. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
16. Karlsson M.G.E., Ludvigsson J. Determination of mRNA expression for IFN-γ and IL-4 in lymphocytes from children with IDDM by RT-PCR technique. Diabetes Res. Clin. Pract. 40:1998;21-30.
17. Karlsson M.G.E., Ludvigsson J. Peptide from glutamic acid decarboxylase similar to coxsackie B virus stimulates IFN-γ mRNA expression in Th1-like lymphocytes from children with recent-onset insulin-dependent diabetes mellitus. Acta Diabetol. 35:1998;137-144.
18. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94:1994;2125-2129.
19. Romagnani S. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:1995;121-129.
20. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
21. Cheung R., Karjalainen J., Vandermeulen J., Singal D.P., Dosch H.-M. T cells from children with IDDM are sensitized to bovine serum albumin. Scand. J. Immunol. 40:1994;623-628.
22. Worsaae A., Hejnaes K., Moddy A., Ludvigsson J., Pociot F., Lorenzen T. et al. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity. 22:1995;183-189.
23. Hallewell R.A., Masiarz F.R., Najarian R.C., Puma J.P., Quiroga M.R., Randolph A. et al. Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res. 13:1985;2017-2034.
24. Arai N., Nomura D., Villaret D., DeWaal Malefijt R., Seiki M., Yoshida M. et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J. Immunol. 142:1989;274-282.
25. Gray P.W., Goeddel D.V. Structure of the human immune interferon gene. Nature. 298:1982;859-863.
26. Tang H., Matthes T., Carballido-Perrig N., Zubler R.H., Kindler V. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA. Eur. J. Immunol. 23:1993;899-903.
27. Heding L.G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 11:1975;541-548.
28. G.F. Bottazzo, A. Florin-Christensen, D. Doniach, Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies, Lancet ii (1974) 1279-1283.
29. Song Y.H., Li Y., Maclaren N.K. The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol. Today. 17:1996;232-238.
30. Ziegler R., Alper C.A., Awdeh Z.L., Castano L., Brink S.J., Soeldner J.S. et al. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes. 40:1991;709-714.
31. Vaarala O., Saukkonen T., Savilahti E., Klemola T., Åkerblom H.K. Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula. J. Allergy Clin. Immunol. 96:1995;917-923.
32. Li Y., Stefura W.P., Simons F.E.R., Jay F.T., HayGlass K.T. Limiting dilution analysis of antigen stimulated IL-4 and IFN-γ production in human mononuclear cell populations. J. Immunol. Methods. 175:1994;169-179.
33. Saukkonen T., Savilahti E., Landin-Olsson M., Dahlqvist G. IgA bovine serum albumin antibodies are increased in newly diagnosed patients with insulin-dependent diabetes mellitus, but the increase is not an independent risk factor for diabetes. Acta Pediatr. 84:1995;1258-1261.
34. Atkinson M.A., Bowman M.A., Kao K.J., Campbell L., Dush P.J., Shah S.C. et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N. Engl. J. Med. 329:1993;1853-1858.